Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹2.7 LQualified Make: Trivitron Healthcare
Model: Biocard Pro COVID-19 Rapid Antigen NO 15 ABHIRAMPURAM IV STREET CHENNAI CHENNAI TAMIL NADU 600018 | CHENNAI | TAMIL NADU | 600018 | Make: Trivitron Healthcare
Model: Biocard Pro COVID-19 Rapid Antigen | L1 | Qualified MSE, Category: General | |
| 2 | L2₹4.5 L+₹1.8 L (66.7%)Qualified Make: standard Q
Model: Standard Q PLOT NO 63 UDYOG VIHAR PH IV GURUGRAM 122015 GURGAON HARYANA 122001 | GURUGRAM | HARYANA | 122015 | Make: standard Q
Model: Standard Q | L2 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
30 Apr 2021, 3:00 pmClosed
Rapid Antigen Test Kits for Novel Corona Virus (SARS- CoV-2/COVID-19)
2318186
GEM/2021/B/1191586
GeM Contract
Rapid Antigen Test Kits for Novel Corona Virus (SARS-CoV-2/COVID-19)
GeM Contract
30 days
Madhya Pradesh; Singrauli
Total value wise evaluation
PRODUCT
Awarded to TRIVITRON HEALTHCARE PRIVATE LIMITED
₹2.7 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Trivitron Healthcare Rapid Antigen | Trivitron Healthcare / Biocard Pro COVID-19 Rapid Antigen | HSN not specified by seller | 2,000 Test | ₹134.40 | 268,800 |
2 documents required · 2 mandatory
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Rapid Antigen Test Kits for Novel Corona Virus (SARS- CoV-2/COVID-19) | - | 2,000 | - |
Exempted
9 May 2021
27 Apr 2021
30 Apr 2021
contract_GEMC-511687764257870.pdf
GEM_CONTRACT • 0.05 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_2318186.pdf
GEM_BID
termsCondition.pdf
OTHER
2657c7ca70287299b5181580fdb5a7ab.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .